Twist Bioscience Corp (NAS:TWST)
$ 85.42 -3.08 (-3.48%) Market Cap: 5.32 Bil Enterprise Value: 5.25 Bil PE Ratio: 0 PB Ratio: 11.68 GF Score: 69/100

Q2 2026 Twist Bioscience Corp Earnings Call Transcript

May 04, 2026 / 12:00PM GMT
Release Date Price: $56.19 (-6.97%)
Operator

Welcome to Twist Biosciences 2026 second quarter financial results conference call. (Operator Instructions) Also note, this call is being recorded. I would now like to turn the call over to Angela Bitting, SVP of Corporate Affairs. Please go ahead.

Angela Bitting;Chief Corporate Responsibility Officer
Twist Bioscience Corp - Senior Vice President - Corporate Affairs

Thank you, operator. Good morning, everyone. I would like to thank you for joining us for Twist Biosciences conference call to review our fiscal 2026 second quarter financial results and business progress. We issued our financial results press release before the market, and it is available at our website at www.twistbiocience.com. With me on the call today tare Dr. Emily Leproust, CEO and Co-Founder of Twist; Adam Laponis, CFO of Twist; and Dr. Patrick Finn, President and COO of Twist.

Today, we will discuss our business progress, financial and operational performance as well as growth opportunities. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot